CeNeS Pharmaceuticals PLC: Clinical Trial Results
20 sept. 2004 04h02 HE
|
CeNeS Pharmaceuticals PLC
CAMBRDIGE, U.K., Sept. 20, 2004 (PRIMEZONE) -- CeNeS Announces Positive Preliminary Results with M6G from Phase III Trial in Post-operative Pain
Cambridge, UK, 20 September 2004 - CeNeS...
CeNeS Reports 2004 Interim Results
20 sept. 2004 02h17 HE
|
CeNeS Pharmaceuticals PLC
CAMBRIDGE, U.K., Sept. 20, 2004 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (AIM:CEN) ("CeNeS" or "the Company") today announced its unaudited interim financial results for the six months ended 30 June...
CeNeS Pharmaceuticals PLC announces Preliminary Results
20 avr. 2004 02h02 HE
|
CeNeS Pharmaceuticals PLC
CAMBRIDGE, United Kingdom, April 20, 2004 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) ("CeNeS" or "the Company") today announced its preliminary results for the year ended 31 December...
CeNeS Reports 2003 Interim Results
30 sept. 2003 02h55 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, Sept. 30, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced its unaudited interim financial results for the six months ended 30 June...
CeNeS announces additional data on M6G to be presented at leading pain conferences
01 sept. 2003 02h15 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, Sept. 01, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that additional data will be presented in the next two months on the...
CeNeS Announces Placing of 17,441,296 New Ordinary Shares
08 août 2003 10h19 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, U.K., Aug. 8, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc ("CeNeS" or "the Company") (LSE:CEN) (Other OTC:CPHAF) is pleased to announce that, subject to the satisfaction of certain...
CeNeS Announces Update On The Status Of Its Clinical Development Programmes Focused On The Treatment Of Pain
02 juil. 2003 02h50 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, July 2, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced that it has finalised its plans for the Phase III trials of M6G (morphine-6-glucuronide) for...
CeNeS Announces Move to AIM
02 juil. 2003 02h35 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, July 2, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced that the board has resolved to apply for the Company's shares to be admitted to AIM...
CeNeS Announces Termination of its Joint Venture with Elan
18 juin 2003 02h27 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, June 18, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced that it has reached agreement with Elan Corporation plc (NYSE:ELN) to terminate the...
CeNeS Announces Completion of Sale of Pharmaceutical Products Raising a Total of Over 9m Pounds in Cash
22 mai 2003 02h45 HE
|
CeNeS Pharmaceuticals Plc
CAMBRIDGE, United Kingdom, May 22, 2003 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced that it has completed the sale of three of its pharmaceutical products for...